Skip to main content

Drug-Target Interactions of 5HT2B Receptors and Its Inhibitors

Project Team: Jakob Magolan (PI), Xiong Zhang, Jagdish Patel

Depression is a common psychiatric disorder. According to the most prevalent monoamine theory, depression is caused by an imbalance of brain neurotransmitters: serotonin, noradrenaline, and dopamine. All currently available antidepressant drugs act mainly by increasing the concentration of these in the brain. Primary drawbacks of current antidepressant drugs are undesirable side effects and late onset of action. Additionally, these drugs are characterized by relatively low efficacy. There is no ideal medication on the market and new antidepressant drugs are needed. Therefore, our goal is to identify new compounds based on a natural product scaffold with increased affinity for 5-HT2B receptor using molecular modeling and synthesize them in the lab to measure their experimental affinities.

Comparison of Two Phasitron Designs for IPV

Project Team: Tao Xing (PI), Gordon Murdoch (co-PI) and Rabijit Dutta (co-PI)

With support from Percussionaire Corp based in Sagle, Idaho, the team will test the new Phasitron design. They will compare the pressure and tidal volumes and the net flow entertainment under various lung conditions. They will also explore computational fluid dynamics (CFD) simulations of the two Phasitron devices. This project and funding grew from the Pilot Project, Multi Scale Model of Interactions Between Lung and Pulmonary Ventilation.

Modeling Idaho Health (MIH)

Working Group leader: Helen Brown

Group members: Christopher Murphy, Erich Seamon, Chris Williams, Nurbanu Bursa, Jennifer Hinds

Originated: November 2016

Description:

This working group started out as, “Small Area Estimation of Obesity-related Indicators (Modeling Obesity Indicators – MOI).”

MIH has continued to refine and expand work to generate small-area estimates (SAE) of Idaho health indicators at a county level using data from the American Community Survey (ACS) and Behavioral Risk Factor Surveillance System (BRFSS). We have worked to refine the model with the goal of identifying counties with higher prevalence of overweight, obesity and, diabetes. We created an interactive dashboard of the health indicators and are in process of expanding this work to include other health indicators.

Publications:

Initiating a watch list for Ebola virus antibody escape mutations

Miller CR, Johnson EL, Burke AZ, Martin KP, Miura TA, Wichman HA, Brown CJ, Ytreberg FM (2016) Initiating a watch list for Ebola virus antibody escape mutations. PeerJ 4:e1674.

Evolution of Tandemly-Replicated Opsin Genes: Molecular Models That Predict Spectral Shifts

Evolution of Tandemly-Replicated Opsin Genes: Molecular Models That Predict Spectral Shifts

A snapshot from an atomistic molecular simulation of a vertebrate cone visual pigment (green – opsin, red – retinal, magenta – palmitoyl moiety) embedded in an explicit lipid bilayer (yellow & purple – lipid head group, grey – lipid tail) and surrounded by a layer of water molecules (cyan).

 

 

Working Group leader: Deborah Stenkamp

Group members: Jagdish Patel, Marty Ytreberg

Originated: Summer 2016

Description:

This working group on an as-needed basis, to discuss progress and approaches for modeling a set of tandemly-replicated cone opsins from the zebrafish, medaka, cichlid, and guppy. They selected these RH2-type cone opsins based upon the availability of a reasonable (reasonably homologous) model from an X-ray crystallography structure, and reliable information from the literature regarding sequence data and spectral sensitivity data.

Docking models attempted on these opsins did not predict spectral shift.

Standard all-atom molecular dynamics simulations were then performed to find out if these predict spectral shift. Challenges that were overcome included modeling of the covalently attached chromophore, and the influence of the surrounding lipid bilayer. In addition, we included three “ancestral” RH2 opsins with known spectral sensitivities to increase the scope of the study to seven RH2 opsins.

The molecular dynamics simulations were carried out in December 2016. Visualization of the distinct fluctuations and analysis of internal parameters associated with the chromophore’s heavy atoms suggested that some of these features may predict spectral shift, and quantitative/statistical approaches to determine if this is the case are underway.

RH2 cone opsins of medaka, guppy, and cichlid were added to the analysis to increase the robustness of our approach, providing a total of 14 distinct RH2 sequences. Two of the output metrics (RMSF and the C7-C6-C5-C18 Torsion) were identified as most highly predictive of “blue” vs. “green” peak spectral sensitivity. A mathematical model was generated, using these two parameters, which predicts spectral sensitivity with a correlative R2 of 0.94 (!!!!).

The manuscript was submitted in fall 2017 – to Cell, then PNAS, then PLOS Biology, and then eLife. The editorial staff at each journal considered it more appropriate for a specialty journal. In December 2017 we submitted it to PLOS Computational Biology. It was favorably reviewed, and after minor revisions, accepted. It is now published, with an epub date of January 24, 2018.

Publications:

Predicting peak spectral sensitivities of vertebrate cone visual pigments using atomistic molecular simulations

Patel JS, Brown CJ, Ytreberg FM, Stenkamp DL (2018) Predicting peak spectral sensitivities of vertebrate cone visual pigments using atomistic molecular simulations. PLoS Comput Biol 14(1): e1005974. https://doi.org/10.1371/journal.pcbi.1005974

Transmissible Vaccines (Trans Vax)

Working Group leader: Jim Bull

Group members: Scott Nuismer, Chris Remein, Courtney Schreiner, Tanner Varrelman, Nathan Layman, Andrew Basinski, Anna Sjodin, Breanna Sipley, Beth Tuschhoff

Originated: Summer 2016

Description:

We develop theory for transmissible vaccines while generating papers and training students and postdocs.

Publications:

Nuismer SL, Basinski A, Bull JJ. 2019. Evolution and containment of transmissible recombinant vector vaccines.  Evol Appl. 2019 Jun 12;12(8):1595-1609.

Bull JJ, Nuismer SL, Antia R. 2019. Recombinant vector vaccine evolution.  PLoS Comput Biol. 15(7):e1006857.

Varrelman TJ, Basinski AJ, Remien CH, Nuismer SL. 2019. Transmissible vaccines in heterogeneous populations: Implications for vaccine design. One Health. 7:100084.

Basinski AJ, Nuismer SL, Remien CH. 2019.  A little goes a long way: Weak vaccine transmission facilitates oral vaccination campaigns against zoonotic pathogens.  PLoS Negl Trop Dis. 13(3):e0007251.

Smithson MW, Basinki AJ, Nuismer SL, Bull JJ. 2019. Transmissible vaccines whose dissemination rates vary through time, with applications to wildlife. Vaccine 37(9):1153-1159.

Basinski AJ, Varrelman TJ, Smithson MW, May RH, Remien CH, Nuismer SL. 2018.  Evaluating the promise of recombinant transmissible vaccines. Vaccine 36(5):675-682.

Bull JJ, Smithson MW, Nuismer SL. 2018. Transmissible Viral Vaccines.  Trends Microbiol.  26(1):6-15.